Significant Ownership of Bellevue Group AG
- Signature - Title
- /s/ Stefano Montalbano - Stefano Montalbano/ Chief Financial Officer
- Location
- Zurich
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Bellevue Group AG.
Follow Filing Activity
Follow Bellevue Group AG and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Bellevue Group AG
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | Common Stock | 6.8% | $46,307,688 | 3,341,103 | Bellevue Group AG | 16 Dec 2025 | ||
| IMCR | Immunocore Holdings plc | Ordinary shares | 5.6% | $101,607,853 | 2,796,803 | Bellevue Group AG | 20 Aug 2025 | ||
| CLDX | Celldex Therapeutics, Inc. | Common Stock | 5.4% | $93,589,097 | 3,617,669 | Bellevue Group AG | 18 Aug 2025 | ||
| MGNX | MacroGenics, Inc. | Common Stock | 0% | $0 | -$13,901,948 | 0 | -100% | Bellevue Group AG | 05 Dec 2025 |
| AGIO | Agios Pharmaceuticals, Inc. | Common Stock | 0% | $0 | -$142,398,726 | 0 | -100% | Bellevue Group AG | 19 Nov 2025 |
Schedules 13D/G Reported by Bellevue Group AG:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.